BIOREGULATORY DRUGS IN THE THERAPY OF NONALCOHOLIC FATTY LIVER DISEASE

DOI: https://doi.org/10.29296/25877305-2018-03-23
Download full text PDF
Issue: 
3
Year: 
2018

Professor M. Maksimov, MD Kazan State Medical Academy

The main task of pharmacotherapy for nonalcoholic fatty liver disease is to prevent the development and progression of liver fibrosis. Currently, there are disputes about the efficacy of these or those hepatoprotectors; the ambiguity of this issue makes one search for optimal approaches to treating patients with liver disease.
Keywords: 
hepatology
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
hepatoprotectors
bioregulatory therapy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Bueverov A.O. Nealkogol'naja zhirovaja bolezn' pecheni i nealkogol'nyj steatogepatit // Vrach. – 2006; 7: 33–7.
  2. Drapkina O.M., Ivashkin V.T. Epidemiologicheskie osobennosti nealkogol'noj zhirovoj bolezni pecheni v Rossii (rezul'taty otkrytogo mnogotsentrovogo prospektivnogo issledovanija-nabljudenija DIREGL 01903) // Ros. zhurn. gastroenterol. gepatol. i koloproktol. – 2014; 24 (4): 32–8.
  3. Ivashkin V.T. Diagnostika i lechenie nealkogol'noj zhirovoj bolezni pecheni: metod. rekomendatsii dlja vrachej / ROPIP, 2015; 38 c.
  4. Mar'janovskij A.A., Shilov A.M. Effektivnaja farmakoterapija // Gastroenterologija. – 2014; 1 (13): 20–6.
  5. Minushkin O.N. Gepatoprotektory: vybor preparata, prodolzhitel'nost' lechenija, otsenka effektivnosti. Posobie dlja vrachej obschej praktiki i gastroenterologov / M., 2014; 53 s.
  6. Gebhardt R. Antioxidative, Antiproliferative and Biochemical Effects in HepG2 Cells of a Homeopathic Remedy and its Constituent Plant Tinctures Tested// Separately or in Combination // J. Biomed. Ther. – 2004; 3: 8–12.